Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,134 | -4,067 | -2,928 | -2,252 | -1,215 |
| Accounts payable and accrued liabilities | -54 | -231 | -219 | -4 | 222 |
| Other Working Capital | -172 | 167 | 43 | 212 | 342 |
| Other Operating Activity | 597 | 1,253 | 888 | 504 | 29 |
| Operating Cash Flow | $-763 | $-2,878 | $-2,217 | $-1,540 | $-622 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 583 | 2,343 | 1,860 | 1,395 | 1,395 |
| Financing Cash Flow | $583 | $2,343 | $1,860 | $1,395 | $1,395 |
| Exchange Rate Effect | -7 | -9 | -4 | -7 | -1 |
| Beginning Cash Position | 515 | 1,060 | 1,060 | 1,060 | 1,060 |
| End Cash Position | 328 | 515 | 700 | 907 | 1,831 |
| Net Cash Flow | $-188 | $-545 | $-360 | $-152 | $772 |
| Free Cash Flow | |||||
| Operating Cash Flow | -763 | -2,878 | -2,217 | -1,540 | -622 |
| Free Cash Flow | -763 | -2,878 | -2,217 | -1,540 | -622 |